Hexarelin
Experimental Growth-Hormone Secretagogue
Hexarelin is a synthetic growth-hormone secretagogue receptor agonist hexapeptide. It was studied experimentally by several routes but is not an approved self-administered peptide, and GH response does not establish parent exposure or long-term safety.
Pharmacokinetic model
A route-level PK model for hexarelin is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Growth-Hormone Secretagogue
- Suggested cadence
- once daily
Research behind this entry
-
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man
Twelve healthy volunteers received hexarelin intravenously, subcutaneously, intranasally, and orally. GH-response AUC suggested route differences, but the experiment measured pharmacodynamic GH release rather than…
1 published study referenced in the app, each with a plain-language summary.